Clinical Trial Update: Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating iadademstat with a hypomethylating agent in patients with myelodysplastic syndromes. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Hypomethylating agent
• Iadademstat (iadademstat)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING